The programme has been developed steadily over the past 11 years (since 2000). Since 2011, the programme has been part of the VLC/CAMPUS, Valencia International Campus of Excellence, launched by the public universities of the City of Valencia and the research centres belonging to the Spanish National Research Council (CSIC) from the autonomous region.

221 Does temporal arteritis headache or other pain respond to non-steroidal anti-inflammatory drugs?

222 What is the recommended target of total and low-density lipoprotein (LDL) cholesterol in secondary prevention of ischaemic stroke?

223 Is intravenous sodium nitroprusside contraindicated in lowering resistant hypertension secondary to primary intracerebral haemorrhage?

224 After how long can a patient with primary intracerebral haemorrhage safely be prescribed aspirin for secondary prophylaxis of further ischemic strokes? Or should aspirin no longer be prescribed in this case?

225 Does occlusion of the recurrent Heubner's artery result in weakness of the upper limb that is proximal more than distal?

226 I have recently been told by fellow cardiologists that statins have a role to play in the acute management of myocardial infarction: is this true? And does this extend to the acute management of ischemic stroke?

227 What is captocormia?

228 Should mannitol be prescribed to patients with primary intracerebral haemorrhage with signs of impending herniation and is it contraindicated in patients with heart failure or liver cell failure?

229 What is the clinical significance of a positive Babinski sign with no knee jerk?

230 Is a high serum level of triglycerides 200-400 mg a risk factor for ischaemic stroke?